Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Bahrain has been growing steadily in recent years.
Customer preferences: Bahrain has a high demand for vaccines due to the government's commitment to providing free healthcare to its citizens. The country has a well-established healthcare system that is accessible to all citizens and residents. The government has also launched several vaccination campaigns in recent years to increase awareness about the importance of vaccines and to encourage people to get vaccinated.
Trends in the market: The vaccines market in Bahrain has been growing steadily due to the increasing demand for vaccines. The country has a high vaccination rate, and the government has been investing heavily in the development and distribution of vaccines. The COVID-19 pandemic has also had a significant impact on the vaccines market in Bahrain. The government has been working closely with vaccine manufacturers to secure vaccines for its citizens and residents.
Local special circumstances: Bahrain is a small island country with a population of around 1.7 million people. The country has a high standard of living and a well-developed economy. The healthcare sector in Bahrain is highly regulated, and all healthcare providers must meet strict standards set by the government. The government also provides free healthcare to all citizens and residents, which has helped to increase the demand for vaccines.
Underlying macroeconomic factors: Bahrain has a highly developed economy, with a strong focus on the service sector. The country has a high GDP per capita, which has helped to drive demand for healthcare services, including vaccines. The government has also been investing heavily in infrastructure development, which has helped to improve access to healthcare services across the country. The country's strategic location in the Gulf region has also made it an attractive destination for international healthcare providers, which has helped to boost the vaccines market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
